Skip to main content
Clinical Trials/NCT03259568
NCT03259568
Terminated
Not Applicable

Effects of rTMS on Human Brain Activity Measured With fMRI

Duke University1 site in 1 country27 target enrollmentJanuary 12, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Human Brain Activity
Sponsor
Duke University
Enrollment
27
Locations
1
Primary Endpoint
Activation of Cortical Networks During a Visual Motion Task.
Status
Terminated
Last Updated
3 years ago

Overview

Brief Summary

This project investigates the effects of repetitive transcranial magnetic stimulation (rTMS) on neural circuits as a function of spatiotemporal parameters and brain state in order to better understand why the method works and how to improve its efficacy. Leveraging our expertise in application of TMS methodology during concurrent single neuron recording techniques in non-human primates and imaging and scalp potential techniques in humans, the investigators aim to resolve three interlocking problems in the design and application of rTMS: stimulation frequency, spatial targeting, and interactions with brain state.

Registry
clinicaltrials.gov
Start Date
January 12, 2018
End Date
August 20, 2019
Last Updated
3 years ago
Study Type
Interventional
Study Design
Factorial
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age between 18-
  • Use of effective method of birth control for women of childbearing capacity.
  • Willing to provide informed consent.

Exclusion Criteria

  • Current or recent (within the past 6 months) of substance abuse or dependence, excluding nicotine and caffeine (urine test).
  • Current serious medical illness (self report).
  • History of seizure except those therapeutically induced by ECT (childhood febrile seizures are acceptable and these subjects may be included in the study), history of epilepsy in self or first degree relatives, stroke, brain surgery, head injury, cranial metal implants, known structural brain lesion, devices that may be affected by rTMS or MRI (pacemaker, medication pump, cochlear implant, implanted brain stimulator); \[TMS Adult Safety Screening (TASS) form\].
  • Subjects are unable or unwilling to give informed consent.
  • Diagnosed any Axis I DSM-IV disorder (MINI, DSM-IV)
  • Subjects with a clinically defined neurological disorder including, but not limited to:
  • Any condition likely to be associated with increased intracranial pressure
  • Space occupying brain lesion.
  • History of stroke.
  • Transient ischemic attack within two years.

Outcomes

Primary Outcomes

Activation of Cortical Networks During a Visual Motion Task.

Time Frame: during each TMS session, up to 3 hours

Acute effect of a rTMS session on fMRI activation during a motion task, as measured by the change in BOLD signal

Reaction Time

Time Frame: during each TMS session, up to 3 hours

Acute effect of a rTMS session on the performance for a motion task, as measured by reaction time (in ms)

Motion Perception Accuracy

Time Frame: during each TMS session, up to 3 hours

Acute effect of a rTMS session on the performance for a motion task, as measured by accuracy (in percentage of correct responses)

Study Sites (1)

Loading locations...

Similar Trials